| Financial Year |
March 31 2023 |
| Monetary Funds |
610,274,004.15 |
| Held-for-trading Financial Assets |
31,500,000.00 |
| Notes Receivable |
341,860,300.32 |
| Accounts Receivable |
2,575,926,145.18 |
| Advances to Suppliers |
225,374,150.33 |
| Other Receivables |
25,086,261.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,683,280,206.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,898,589.70 |
| Total Current Assets |
5,881,943,395.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,255,639.29 |
| Long-term Equity Investment |
46,102,273.56 |
| Investment Properties |
-- |
| Fixed Assetes |
1,551,115,696.24 |
| Under-construction Projects |
491,250,766.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
362,759,578.30 |
| R&D expenses |
-- |
| Goodwill |
430,307,219.77 |
| Long-Term Deferred and Prepaid Expenses |
12,453,220.27 |
| Deferred Income Tax Assets |
73,327,777.71 |
| Other Non-Current Assets |
47,399,247.23 |
| Sub-Total of Non-Current Assets |
3,092,461,124.90 |
| Total Assets |
8,974,404,520.03 |
| Short-Term Loans |
2,426,890,093.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
537,517,349.73 |
| Accounts Payable |
1,106,869,242.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
55,361,061.15 |
| Taxes Payable |
8,860,057.92 |
| Interest Payable |
-- |
| Dividend Payable |
26,976,087.00 |
| Other payables |
335,730,651.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
73,059,369.60 |
| Other Current Liabilities |
5,177,759.96 |
| Sub-Total of Current Liabilities |
4,625,089,891.22 |
| Long-term Loans |
1,036,374,126.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,297,011.27 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
38,920,800.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,138,115,326.14 |
| Total Liabilities |
5,763,205,217.36 |
| Paid-In Capital(Or Share Stock) |
1,017,431,917.00 |
| Capital Surplus |
257,799,675.61 |
| Surplus Reserve |
184,188,949.58 |
| LESS:Treasury Stock |
107,839,712.01 |
| Undistributed Profits |
1,533,700,445.71 |
| Minority Stockholder's Interest |
275,623,420.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,935,575,882.07 |
| Owner's Equity（Stockholder's Equity） |
3,211,199,302.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,974,404,520.03 |
